Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Gut

• Publication date

  2003-08-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/gut.52.9.1371PMID 12912872PMCID PMC1773789
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of ursodeoxycholic acid bioavailability from immediate- and sustained-release preparations using gas chromatography-mass spectrometry and high-performance liquid chromatography.

  2011cited by this paper
• Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases

  2001cited by this paper
• Downregulation of ileal bile acid absorption in bile-duct-ligated rats.

  2000cited by this paper
• Mitochondrial membrane perturbations in cholestasis.

  2000cited by this paper
• Identification of a Bile Acid-responsive Element in the Human Ileal Bile Acid-binding Protein Gene

  1999cited by this paper
• Regulation of ileal bile acid transport: Desirability of measuring transport function as well as transporter activity

  1999influential reference
• Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine‐conjugated species in patients with primary biliary cirrhosis

  1999cited by this paper
• Neither intestinal sequestration of bile acids nor common bile duct ligation modulate the expression and function of the rat ileal bile acid transporter

  1998cited by this paper
• Molecular analysis of the adaptive response of intestinal bile acid transport after ileal resection in the rat.

  1998cited by this paper
• Induction of sodium-dependent bile acid transporter messenger RNA, protein, and activity in rat ileum by cholic acid.

  1997cited by this paper
• Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.

  1997cited by this paper
• Ileal absorption of bile acids in patients with chronic cholestasis

  1996influential reference
• Adaptive response of the enterohepatic circulation of bile acids to extrahepatic cholestasis

  1996cited by this paper
• Increased gall bladder volume in primary sclerosing cholangitis.

  1996cited by this paper
• Natural history of early primary biliary cirrhosis.

  1996cited by this paper
• Intestinal absorption of bile acids: effect of ursodeoxycholic acid treatment.

  1995cited by this paper
• Downregulation of taurocholate transport by ileal BBM and liver BLM in biliary-diverted rats.

  1994cited by this paper
• Phorbol myristate acetate and ATP-sensitive potassium channels in insulin-secreting cells.

  1994cited by this paper
• Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.

  1994cited by this paper
• [Measurement of ileal absorption of bile salts with the selenium 75 labelled homotaurocholic acid test. Validation and clinical significance].

  1994cited by this paper
• Negative feedback regulation of the ileal bile acid transport system in rodents.

  1993cited by this paper
• Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease

  1992cited by this paper
• Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration

  1991cited by this paper
• Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: In vitro studies in rat hepatocytes and human erythrocytes

  1991cited by this paper
• Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes

  1990cited by this paper
• Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids.

  1990cited by this paper
• Hepatic handling of a synthetic gamma-labeled bile acid (75SeHCAT).

  1988cited by this paper
• Ileal excretion of bile acids: comparison with biliary bile composition and effect of ursodeoxycholic acid treatment.

  1988cited by this paper
• Kinetics for the synthetic bile acid 75selenohomocholic acid-taurine in humans: comparison with [14C]taurocholate.

  1988cited by this paper
• Hepatic handling of a synthetic γ-labeled bile acid (75SeHCAT)

  1988cited by this paper
• Use of a γ-labeled bile acid (75SeHCAT) as a test of ileal function

  1986cited by this paper
• Effects of artificial depletion of the bile acid pool in man.

  1986cited by this paper
• Use of a gamma-labeled bile acid (75SeHCAT) as a test of ileal function. Methods of improving accuracy.

  1986cited by this paper
• Absorbed dose to man from the Se-75 labeled conjugated bile salt SeHCAT: concise communication.

  1982cited by this paper
• Enterohepatic circulation in man of a gamma-emitting bile-acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT).

  1982cited by this paper
• Altered bile acid metabolism in primary biliary cirrhosis

  1981cited by this paper
• Enterohepatic circulation of bile acids after cholecystectomy.

  1978cited by this paper
• Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity.

  1977cited by this paper
• Bile acid pools, kinetics and biliary lipid composition before and after cholecystectomy.

  1973cited by this paper
• The effect of cholecystectomy on bile salt metabolism

  1973cited by this paper
• Sensitivity and specificity in tests of distal ileal function: prospective comparison of bile acid and vitamin B 12 absorption in ileal resection patients.

  1973cited by this paper
• Mechanism of cholestasis.

  1972cited by this paper
• Mechanism of cholestasis. 5. Bile acids in normal rat livers and in those after bile duct ligation.

  1972cited by this paper
• Mechanism of cholestasis. 6. Bile acids in human livers with or without biliary obstruction.

  1972cited by this paper
• Bile acid metabolism in patients with cirrhosis. II. Cholic and chenodeoxycholic acid metabolism.

  1971cited by this paper
• Fecal excretion of bile acids: a new technique for studying bile acid kinetics in patients with ileal resection.

  1971cited by this paper

• Benefits and challenges to therapeutic targeting of bile acid circulation in cholestatic liver disease

  2025cites this paper
• Baicalin restore intestinal damage after early-life antibiotic therapy: the role of the MAPK signaling pathway.

  2024cites this paper
• Synthesis of TUDCA from chicken bile: immobilized dual-enzymatic system for producing artificial bear bile substitute

  2024cites this paper
• Exploring the interplay of Emotional intelligence and stress

  2024cites this paper
• The Role of Bile Acids in the Human Body and in the Development of Diseases

  2022cites this paper
• Primary Biliary Cholangitis (Formerly Primary Biliary Cirrhosis)

  2019cites this paper
• Mechanisms and Treatments of Pruritus in Primary Biliary Cholangitis

  2019cites this paper
• UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications.

  2019cites this paper
• Manual acupuncture relieves bile acid-induced itch in mice: the role of microglia and TNF-α

  2018cites this paper
• Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluations Following Single Oral Doses of GSK2330672 in Healthy Japanese Volunteers

  2018cites this paper
• Understanding and Treating Pruritus in Primary Biliary Cholangitis.

  2018cites this paper
• University of Birmingham Apical Sodium-Dependent Transporter Inhibitors in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis

  2017cites this paper
• Management of Pruritus in Primary Biliary Cholangitis: A Narrative Review.

  2017cites this paper
• Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study.

  2017cites this paper
• Autoimmune Liver Diseases: Primary Biliary Cholangitis

  2017cites this paper
• Apical Sodium-Dependent Transporter Inhibitors in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis

  2017cites this paper
• Ursodeoxycholic Acid for the Treatment of Liver Diseases

  2017cites this paper
• BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial

  2016cites this paper
• Serum level of taurine would be associated with the amelioration of minimal hepatic encephalopathy in cirrhotic patients

  2016cites this paper
• Novel bile acid therapeutics for the treatment of chronic liver diseases

  2016cites this paper
• BAT 117213 : Ileal bile acid transporter ( IBAT ) inhibition as a treatment for pruritus in primary biliary cirrhosis : study protocol for a randomised controlled trial

  2016cites this paper
• Prednisolone increases enterohepatic cycling of bile acids by induction of Asbt and promotes reverse cholesterol transport.

  2014cites this paper
• Treatment of primary biliary cirrhosis

  2014cites this paper
• Conformational dynamics of human FXR-LBD ligand interactions studied by hydrogen/deuterium exchange mass spectrometry: insights into the antagonism of the hypolipidemic agent Z-guggulsterone.

  2014cites this paper
• An overview of current and future therapeutic strategies for the treatment of primary sclerosing cholangitis

  2014cites this paper
• Gut microbiota and nuclear receptors in bile acid and lipid metabolism

  2014cites this paper
• Bile Formation and the Enterohepatic Circulation

  2012cites this paper
• Options for Treatment of Primary Biliary Cirrhosis

  2012cites this paper
• Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action.

  2012cites this paper
• Unusual binding of ursodeoxycholic acid to ileal bile acid binding protein: role in activation of FXRα[S]

  2012cites this paper
• Role of bile acids and bile acid receptors in metabolic regulation.

  2009cites this paper
• Bile acids: Trying to understand their chemistry and biology with the hope of helping patients

  2009cites this paper
• Nuclear receptor ligands in therapy of cholestatic liver disease.

  2009cites this paper
• Bile acid transporters

  2009cites this paper
• Intestinal bile acid physiology and pathophysiology.

  2008cites this paper
• Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasis.

  2008cites this paper
• Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasis

  2008cites this paper
• Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.

  2006cites this paper
• Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis

  2006cites this paper
• CHAPTER 56 – Bile Formation and the Enterohepatic Circulation

  2006cites this paper
• c-Fos is a critical mediator of inflammatory-mediated repression of the apical sodium-dependent bile acid transporter.

  2006cites this paper
• Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis

  2005cites this paper
• Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis.

  2005influential citation
• Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: role of the farnesoid X receptor.

  2005cites this paper
• Bile acid–induced negative feedback regulation of the human ileal bile acid transporter

  2004cites this paper
• Cholestatic syndromes.

  2004cites this paper
• Bile acid-induced negative feedback regulation of the human ileal bile acid transporter.

  2003cites this paper
• Keeping neuroendocrine cells in check: roles for TGFβ, Smads, and menin?

  2003cites this paper
• Cholestatic syndromes

  2002cites this paper
• Electron spin resonance ( ESR ) spectroscopy may have a role in the future in assessing the mucosal integrity of the colon non-invasively in the otherwise normal looking colon of patients with quiescent colitis

  year unknowncites this paper